ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,564.41
1.08%
US Tech 100
19,270.40
-0.12%
Dow Jones
40,421.36
0.33%
Brent Oil
81.485
-0.04%
Bitcoin
66,694.98
-1.35%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Korro Bio Inc (KRRO)

  7. Korro Bio Inc (KRRO) News

KRRO

Korro Bio (KRRO)

Korro Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KRRO
DateTimeSourceHeadlineSymbolCompany
07/01/20248:00AMGlobeNewswire Inc.Korro Joins the Russell 2000®, Russell 3000®, and Russell Microcap® IndexesNASDAQ:KRROKorro Bio Inc
06/17/20244:27PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
06/17/20244:22PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
06/12/20245:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
06/12/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
06/12/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
06/04/20247:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
05/30/20244:01PMGlobeNewswire Inc.Korro to Participate in Upcoming June Investor and Scientific ConferencesNASDAQ:KRROKorro Bio Inc
05/23/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KRROKorro Bio Inc
05/22/20244:37PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
05/20/20242:30PMGlobeNewswire Inc.Korro Presents Additional Preclinical Data for KRRO-110 at the American Thoracic Society 2024 International ConferenceNASDAQ:KRROKorro Bio Inc
05/14/20248:22PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRROKorro Bio Inc
05/14/20244:34PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:KRROKorro Bio Inc
05/14/20244:20PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
05/14/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
05/14/20244:02PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRROKorro Bio Inc
05/14/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
05/14/20244:01PMGlobeNewswire Inc.Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical OfficerNASDAQ:KRROKorro Bio Inc
04/18/20248:30AMGlobeNewswire Inc.Korro Announces $70 Million Private PlacementNASDAQ:KRROKorro Bio Inc
04/01/20244:01PMGlobeNewswire Inc.Korro to Participate in Upcoming Investor ConferencesNASDAQ:KRROKorro Bio Inc
03/26/20244:01PMGlobeNewswire Inc.Korro Reports Full Year 2023 Financial Results and Highlights Recent ProgressNASDAQ:KRROKorro Bio Inc
02/27/20248:00AMGlobeNewswire Inc.Korro to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:KRROKorro Bio Inc
01/18/20248:00AMGlobeNewswire Inc.Korro Bio Highlights Data for its Lead Program in Alpha-1 Antitrypsin Deficiency (AATD) and Progress Across its RNA Editing PortfolioNASDAQ:KRROKorro Bio Inc
01/09/20249:02AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
01/09/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRROKorro Bio Inc
01/04/20248:00AMGlobeNewswire Inc.Korro to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:KRROKorro Bio Inc
12/26/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:KRROKorro Bio Inc
12/22/20234:31PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:KRROKorro Bio Inc
12/20/20234:44PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:KRROKorro Bio Inc
12/07/20238:00AMGlobeNewswire Inc.Korro Announces Selection of its First Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD)NASDAQ:KRROKorro Bio Inc
 Showing the most relevant articles for your search:NASDAQ:KRRO

Your Recent History

USOTC
ITUP
Interups (CE)
USOTC
IDVV
International Endeavors (PK)
NYSE
AMC
AMC Entertainment
USOTC
MGON
Megola (PK)
USOTC
AABB
Asia Broadband (PK)
USOTC
GRLT
Grillit (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
ECSL
Ecare Solutions (PK)
USOTC
CNNA
Cann American (CE)
USOTC
NBRI
North Bay Resources (PK)
NASDAQ
LWLG
Lightwave Logic
USOTC
HIRU
Hiru (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
ELTP
Elite Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved